Many of these canonical NF-κB target genes, including IL-1β, IL-6 and IL-8, have been associated with melanoma tumorigenicity, metastasis and angiogenesis, and represent potential targets for therapy [38, 49, 50]. This evidence concerns the gene CXCL8 and melanoma.